Crossmark

Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-022-01633-6

Published Online: 2022-03-10

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ueno, Toshiyuki https://orcid.org/0000-0002-6803-6179
Ohta, Takanori

Sugio, Yasuhiro

Ohno, Yuju

Uehara, Yasufumi
License Information

Text and Data Mining valid from 2022-03-10

Version of Record valid from 2022-03-10
More Information

Article History

Received: 8 January 2022

Revised: 23 February 2022

Accepted: 24 February 2022

First Online: 10 March 2022

Competing interests

: The authors declare no competing interests.

: The patient has provided informed consent for the publication of this case presentation.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below